Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 47, 2017 - Issue 3
739
Views
14
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

Disposition and metabolism of TAK-438 (vonoprazan fumarate), a novel potassium-competitive acid blocker, in rats and dogs

, , , , , , , , , & show all
Pages 255-266 | Received 07 Mar 2016, Accepted 21 Apr 2016, Published online: 26 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Shan Zhou, Fang-Ling Zhao, Shuang-Hu Wang, Yi-Ran Wang, Yun Hong, Quan Zhou, Pei-Wu Geng, Qing-Feng Luo, Jian-Ping Cai & Da-Peng Dai. (2023) Assessments of CYP‑inhibition‑based drug–drug interaction between vonoprazan and poziotinib in vitro and in vivo. Pharmaceutical Biology 61:1, pages 356-361.
Read now
Yun Hong, Da-Peng Dai, Jian-Ping Cai, Shuang-Hu Wang, Yi-Ran Wang, Fang-Ling Zhao, Shan Zhou, Quan Zhou, Pei-Wu Geng, Yun-Fang Zhou, Xue Xu, Ji-Hua Shi & Qing-Feng Luo. (2022) Effects of Simvastatin on the Metabolism of Vonoprazan in Rats Both in vitro and in vivo. Drug Design, Development and Therapy 16, pages 1779-1789.
Read now
Jiquan Shen, Bo Wang, Shuanghu Wang, Feifei Chen, Deru Meng, Hui Jiang, Yunfang Zhou, Peiwu Geng, Quan Zhou & Bin Liu. (2020) Effects of Voriconazole on the Pharmacokinetics of Vonoprazan in Rats. Drug Design, Development and Therapy 14, pages 2199-2206.
Read now
Hitomi Yamasaki, Naohiro Kawaguchi, Masami Nonaka, Junzo Takahashi, Akio Morohashi, Hideki Hirabayashi, Toshiya Moriwaki & Satoru Asahi. (2017) In vitro metabolism of TAK-438, vonoprazan fumarate, a novel potassium-competitive acid blocker. Xenobiotica 47:12, pages 1027-1034.
Read now
Irene Martinucci, Corrado Blandizzi, Giorgia Bodini, Elisa Marabotto, Vincenzo Savarino, Santino Marchi, Nicola de Bortoli & Edoardo Savarino. (2017) Vonoprazan fumarate for the management of acid-related diseases. Expert Opinion on Pharmacotherapy 18:11, pages 1145-1152.
Read now

Articles from other publishers (9)

Yiran Wang, Jihua Shi, Dapeng Dai, Jianping Cai, Shuanghu Wang, Yun Hong, Shan Zhou, Fangling Zhao, Quan Zhou, Peiwu Geng, Yunfang Zhou, Xue Xu & Qingfeng Luo. (2022) Evaluation of commonly used cardiovascular drugs in inhibiting vonoprazan metabolism in vitro and in vivo. Frontiers in Pharmacology 13.
Crossref
Ming-Shu Wang, Yi Gong, Lin-Sheng Zhuo, Xing-Xing Shi, Yan-Guang Tian, Chang-Kang Huang, Wei Huang & Guang-Fu Yang. (2022) Distribution- and Metabolism-Based Drug Discovery: A Potassium-Competitive Acid Blocker as a Proof of Concept. Research 2022.
Crossref
Yoo-Seong Jeong, Min-Soo Kim, Nora Lee, Areum Lee, Yoon-Jee Chae, Suk-Jae Chung & Kyeong-Ryoon Lee. (2021) Development of Physiologically Based Pharmacokinetic Model for Orally Administered Fexuprazan in Humans. Pharmaceutics 13:6, pages 813.
Crossref
Wei-min Kong, Bin-bin Sun, Zhong-jian Wang, Xiao-ke Zheng, Kai-jing Zhao, Yang Chen, Jia-xin Zhang, Pei-hua Liu, Liang Zhu, Ru-jun Xu, Ping Li, Li Liu & Xiao-dong Liu. (2020) Physiologically based pharmacokinetic–pharmacodynamic modeling for prediction of vonoprazan pharmacokinetics and its inhibition on gastric acid secretion following intravenous/oral administration to rats, dogs and humans. Acta Pharmacologica Sinica 41:6, pages 852-865.
Crossref
Yiran Wang, Changxiong Wang, Shuanghu Wang, Quan Zhou, Dapeng Dai, Jihua Shi, Xue Xu & Qingfeng Luo. (2020) Cytochrome P450-Based Drug-Drug Interactions of Vonoprazan In Vitro and In Vivo. Frontiers in Pharmacology 11.
Crossref
Libin Wang, Shouchang Gai, Xiaorui Zhang, Xiaohui Xu, Nan Gou, Xingchen Wang, Nan Zhou & Tian Feng. (2020) Simultaneous determination of Rivaroxaban and TAK-438 in rat plasma by LC–MS/MS: application to pharmacokinetic interaction study. Bioanalysis 12:1, pages 11-22.
Crossref
Mitsuhiro Nishihara, Hitomi Yamasaki, Richard Czerniak & Helen Jenkins. (2018) In Vitro Assessment of Potential for CYP-Inhibition-Based Drug–Drug Interaction Between Vonoprazan and Clopidogrel. European Journal of Drug Metabolism and Pharmacokinetics 44:2, pages 217-227.
Crossref
Toshio Nishi, Yuta Yamamoto, Naoko Yamagishi, Mikitaka Iguchi, Hideyuki Tamai, Takao Ito, Yoshihiro Tsuruo, Masao Ichinose, Masayuki Kitano & Takashi Ueyama. (2018) Lansoprazole prevents the progression of liver fibrosis in non-alcoholic steatohepatitis model rats. Journal of Pharmacy and Pharmacology 70:3, pages 383-392.
Crossref
Yuan Qiao, Jun Zhao, Xuanfeng Yue, Yang Zhang, Ruitao Zhang, Yuan Xu, Xiuling Tang, Xueying Liu & Qingwei Wang. (2017) Study on pharmacokinetics and bioequivalence of Vonoprazan pyroglutamate in rats by liquid chromatography with tandem mass spectrometry. Journal of Chromatography B 1059, pages 56-65.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.